Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has experienced a change in its substantial holder structure, with Regal Funds Management Pty Ltd and its associates adjusting their voting power to 9.59%, as opposed to the previous 7.99%. This shift is reflected by recent buying and selling of shares, notably a purchase of over 3.27 million ordinary shares. The financial implications of these transactions could be significant for investors and the market.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
